Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

French athlete handed six-month ban for doping
eventing
Livio and the French eventing team lost their slot in the Rio 2016 Olympic Games after the horse tested positive for a banned substance. (stock image)
Sanctions follow failed drugs test

French eventer Maxime Livio has been handed a fine and banned for six months after horse Qalao des Mers tested positive for a controlled medication substance.

A sample taken from the horse on 29 August last year tested positive for hydroxyethylpromazine sulfoxide, which is a metabolite of acepromazine.

After the findings were revealed last month, Livio and the French eventing team were disqualified from the FEI World Equestrian Games 2014. As a result, France lost its slot in the Rio 2016 Olympic Games.

As well as a six-month ban on Livio, which came into effect on 7 May, the FEI Tribunal ordered the athlete to pay CHF 2,500 in addition to covering the costs of the B sample analysis and contributing to the judicial procedure costs.

Acepromazine is a controlled medication substance on the FEI prohibited substances list. The list comprises substances that are regularly used to treat horses but are prohibited in competitions to maintain a level playing field.

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.